Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Clinical trial NCT02605967 · COMPLETED
Trial details
- NCT number
- NCT02605967
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-20
- Primary completion
- 2019-11-05
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.